SecSonar.com

Veru Inc. (VERU)

Veru Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Veru Inc. (VERU) is a Biotechnology company based in US with a market capitalization of $37.4M. Free cash flow was negative at -$30M. This page tracks VERU's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 210 employees · IPO Feb 11, 1999

Valuation

Valuation & price

$2.11 · as of May 17, 2026 · -65.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.04

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.14$4.12$2.09Jul 25Dec 25Jul 26Jul 7, 25$5.84Jul 9, 25$5.54Jul 11, 25$6.01Jul 15, 25$5.81Jul 17, 25$6.14Jul 21, 25$5.80Jul 23, 25$5.85Jul 25, 25$5.61Jul 29, 25$4.92Jul 31, 25$4.85Aug 4, 25$4.80Aug 6, 25$3.66Aug 11, 25$3.59Aug 13, 25$3.41Aug 15, 25$3.59Aug 19, 25$3.24Aug 21, 25$3.55Aug 25, 25$3.49Aug 27, 25$3.29Aug 29, 25$3.25Sep 3, 25$3.31Sep 5, 25$3.37Sep 9, 25$3.47Sep 11, 25$3.56Sep 16, 25$3.68Sep 18, 25$3.57Sep 22, 25$3.57Sep 24, 25$3.45Sep 26, 25$3.73Sep 30, 25$3.80Oct 2, 25$3.86Oct 6, 25$4.01Oct 8, 25$4.41Oct 10, 25$3.93Oct 14, 25$4.15Oct 16, 25$4.17Oct 21, 25$4.30Oct 23, 25$3.72Oct 27, 25$3.80Oct 29, 25$3.50Oct 31, 25$2.95Nov 4, 25$2.56Nov 6, 25$2.52Nov 10, 25$2.60Nov 12, 25$2.73Nov 14, 25$2.54Nov 18, 25$2.53Nov 20, 25$2.23Nov 25, 25$2.39Nov 28, 25$2.48Dec 2, 25$2.36Dec 4, 25$2.42Dec 8, 25$2.65Dec 10, 25$2.57Dec 12, 25$2.42Dec 16, 25$2.44Dec 18, 25$2.26Dec 22, 25$2.29Dec 24, 25$2.34Dec 29, 25$2.21Jan 2, 26$2.27Jan 6, 26$2.33Jan 8, 26$2.31Jan 12, 26$2.27Jan 14, 26$2.34Jan 16, 26$2.69Jan 21, 26$2.59Jan 23, 26$2.80Jan 27, 26$2.68Jan 29, 26$2.61Feb 2, 26$2.57Feb 4, 26$2.53Feb 9, 26$2.39Feb 11, 26$2.30Feb 13, 26$2.29Feb 18, 26$2.42Feb 20, 26$2.50Feb 24, 26$2.61Feb 26, 26$2.66Mar 2, 26$2.62Mar 4, 26$2.51Mar 6, 26$2.47Mar 10, 26$2.47Mar 12, 26$2.46Mar 17, 26$2.41Mar 19, 26$2.29Mar 23, 26$2.30Mar 25, 26$2.29Mar 27, 26$2.09Mar 31, 26$2.21Apr 2, 26$2.29Apr 7, 26$2.48Apr 9, 26$2.43Apr 13, 26$2.38Apr 15, 26$2.43Apr 17, 26$2.44Apr 22, 26$2.44Apr 24, 26$2.32Apr 28, 26$2.29Apr 30, 26$2.25May 4, 26$2.25May 6, 26$2.22May 8, 26$2.24May 12, 26$2.27May 14, 26$2.09May 18, 26$2.12May 20, 26$2.17May 22, 26$2.35May 28, 26$2.32Jun 1, 26$2.38Jun 3, 26$2.25Jun 5, 26$3.40Jun 9, 26$3.10Jun 11, 26$3.26Jun 15, 26$3.13Jun 17, 26$2.99Jun 22, 26$2.96Jun 24, 26$2.97Jun 26, 26$3.01Jul 2, 26$3.06
$2.0952-week range$6.14
Loading valuation history…

Fundamentals

Key fundamentals

$37.4M

Market cap

—

Revenue growth (YoY)

34.7%

Gross margin

-$30M

Free cash flow (USD)

-$15.2M

Net debt

Net cash position

8.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$22.1MFY 2017$13.7MFY 2018$15.9MFY 2019$31.8MFY 2020$42.6MFY 2021$61.3MFY 2022$39.4MFY 2023$16.3MFY 2024$16.9MFY 2025$0.00
$22.1M$0

Free cash flow by year

2016 → 2025

FY 2016$-1.7MFY 2017$849.4KFY 2018$-11.6MFY 2019$-5.6MFY 2020$-2.0MFY 2021$-15.9MFY 2022$-48.2MFY 2023$-88.7MFY 2024$-21.8MFY 2025$-30.0M
-$1.7M-$30M

Gross margin by year

2021 → 2024

FY 202178.2%FY 202277.7%FY 202346.4%FY 202434.7%
78.2%34.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStock Sales AgreementJul 2, 2026Filing
  • 8-K eventClinical Supply AgreementJun 4, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • FinancingSecurities RegistrationApr 7, 2026Filing
  • FinancingSecurities RegistrationApr 7, 2026Filing

Questions

Frequently asked questions

What is Veru Inc.'s market cap?

Veru Inc. (VERU) has a market capitalization of $37.4M.

What is VERU's P/E ratio?

A meaningful P/E ratio is not available for VERU — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VERU's price-to-book (P/B) ratio?

VERU trades at 2.04 times book value per share.

Are insiders buying VERU stock?

SEC Form 4 filings show no open-market insider buys at Veru Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

BTAI

BioXcel Therapeutics, Inc.

$37.1M

ATHE

Alterity Therapeutics Limited

$36.5M

INMB

INmune Bio, Inc.

$36.3M

ATNM

Actinium Pharmaceuticals, Inc.

$38.9M

ALGS

Aligos Therapeutics, Inc.

$35.5M

RNXT

RenovoRx, Inc.

$35M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.